Reflections from RSNA 2025: AI is everywhere, but are we solving the right problems?
RSNA 2025 highlighted a crowded AI landscape—but also the growing complexity of multi-site imaging trials. Learn why scanner variability, protocol...
RSNA 2025 highlighted a crowded AI landscape—but also the growing complexity of multi-site imaging trials. Learn why scanner variability, protocol...
Take a look ahead at our predicted trends for neuroscience in 2025 - where technology, neuroplasticity, and neuroethics are reshaping the way we...
5 warning signs your imaging core facility has outgrown its data infrastructure — from data detective syndrome to compliance gaps — and how modern...
Learn how to integrate AI tools into medical imaging workflows using QMENTA’s cloud platform, including benefits, challenges, and a 3-step SDK...
IBM Watson pioneer Dr. John E. Kelly III shares his perspective on AI adoption barriers, data quality, and the future of AI-enabled neurological...
Discover how the new McDonald criteria use imaging biomarkers such as the Central Vein Sign (CVS) to make earlier, more accurate MS diagnosis
Parkinson’s Disease (PD) is the second most prevalent neurodegenerative disorder worldwide. Over 750 industry clinical trials have been initiated for...
Head-to-head studies of AL001 versus a marketed lithium carbonate product will be conducted for comparisons of lithium blood and...